ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.

December 15, 2000

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

July 11, 1975